One person rbs is 498 mg/dl without any symptoms during rounds ..how t

One person rbs is 498 mg/dl without any symptoms during rounds ..how to manage

Reading File

Searching the Web

asymptomatic hyperglycemia 498 mg/dl inpatient management guidelines 2024

Finding Sources

Reading File

Here is a practical, stepwise management approach for a non-critically ill patient found to have RBS 498 mg/dL with no symptoms during ward rounds:

Immediate Assessment (Do First)

1. Confirm & Rule Out Emergencies

Repeat capillary blood glucose - confirm the reading is real (finger-stick error is common)
Check for DKA signs: nausea, vomiting, abdominal pain, fruity breath, Kussmaul breathing - your patient is asymptomatic, but RBS ≥300 mandates active exclusion
Check for HHS signs: altered sensorium, extreme dehydration - again, rule out even if "asymptomatic"
Investigations to order immediately:
- Serum electrolytes + urea/creatinine
- Urine/serum ketones
- ABG (if ketones positive or any doubt)
- HbA1c (if not done in last 3 months - ADA 2025 recommends this on all admitted hyperglycemic patients)
- Serum osmolality (calculate: 2[Na] + glucose/18 + BUN/2.8)

"Extreme hyperglycemia (≥300 mg/dL) on one or more consecutive tests should prompt testing for ketoacidosis with electrolytes and ketone measurements." - The Washington Manual of Medical Therapeutics

If DKA/HHS Excluded - Non-critical Inpatient Management

2. Stop/Hold Oral Antidiabetic Agents

Discontinue metformin, SGLT2i (risk of euDKA), sulfonylureas
Insulin is the preferred agent for inpatient hyperglycemia control (Endocrine Society & ADA guidelines)

3. Start Scheduled Subcutaneous Insulin (Basal-Bolus Regimen)

Do NOT rely on sliding scale alone - it is reactive, leads to wide fluctuations, and should not be used beyond 12-24 hours.

Starting dose calculation (for insulin-naive patients):

Total Daily Dose (TDD) = 0.2-0.5 units/kg/day (use lower end in elderly, renal impairment)
Example for 60 kg patient: TDD = 12-30 units
- Basal insulin (e.g., Glargine/Detemir): 50% of TDD = 6-15 units once daily
- Premeal rapid-acting insulin (e.g., Aspart/Lispro): 50% of TDD split as 3 equal doses before each meal (only if eating)

For patients already on insulin: reduce dose by 20% on admission, then titrate.

Correction (sliding scale) insulin - add on top of scheduled doses:

Start correction at glucose >140 mg/dL
Add ~1-2 units per 50 mg/dL above 140 mg/dL
Example: at 498 mg/dL, correction dose ~7-14 units of rapid-acting insulin

4. Glucose Monitoring

Check blood glucose 4 times daily (before meals + bedtime)
Target: 140-180 mg/dL for non-ICU patients (ADA 2025, Endocrine Society)
Adjust doses next day based on the day's pattern

Context Matters - Key Questions to Ask

Question	Why It Matters
Known diabetic? On which meds?	Guides dose adjustment
Reason for admission?	Stress hyperglycemia vs uncontrolled diabetes
On steroids/vasopressors/TPN?	Iatrogenic cause - needs specific correction
Eating normally?	Determines premeal insulin vs q4-6h dosing
Renal/hepatic function?	Affects insulin clearance and dosing
Recent HbA1c?	Distinguishes acute decompensation from chronic poor control

Admission Decision

Per Tintinalli's, consider admission/escalation for:

Glucose >400 mg/dL (your patient is close to this) with any metabolic derangement
New-onset hyperglycemia with no clear cause
Inability to manage safely outpatient

Since this patient is already inpatient and asymptomatic, the focus is on initiating the basal-bolus protocol above, rechecking glucose in 4-6 hours, and ensuring morning labs (electrolytes, ketones, HbA1c) are sent.

Summary Protocol

RBS 498 mg/dL, asymptomatic, inpatient

1. Repeat glucose → confirm
2. Send: electrolytes, urine ketones, HbA1c, renal function
3. If ketones positive/acidotic → DKA protocol (IV insulin infusion + fluids)
4. If ketones negative, no acidosis:
   → Hold oral agents + SGLT2i
   → Start basal-bolus insulin:
      Basal: 0.1-0.2 units/kg SC once daily (e.g., Glargine)
      Premeal: 0.1-0.2 units/kg ÷ 3 meals
      Correction: ~10 units rapid-acting NOW for glucose of ~500
   → Monitor glucose QID
   → Target 140-180 mg/dL
5. Adjust doses next morning based on readings

Sources: The Washington Manual of Medical Therapeutics | Tintinalli's Emergency Medicine | ADA Standards of Care 2025 | Endocrine Society Inpatient Hyperglycemia Guidelines

This is a shared conversation. Sign in to Orris to start your own chat.